These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

817 related items for PubMed ID: 17620527

  • 1. Primary percutaneous coronary intervention compared with fibrinolysis for myocardial infarction in diabetes mellitus: results from the Primary Coronary Angioplasty vs Thrombolysis-2 trial.
    Timmer JR, Ottervanger JP, de Boer MJ, Boersma E, Grines CL, Westerhout CM, Simes RJ, Granger CB, Zijlstra F, Primary Coronary Angioplasty vs Thrombolysis-2 Trialists Collaborators Group.
    Arch Intern Med; 2007 Jul 09; 167(13):1353-9. PubMed ID: 17620527
    [Abstract] [Full Text] [Related]

  • 2. Prevalence and prognostic implications of ST-segment deviations from ambulatory Holter monitoring after ST-segment elevation myocardial infarction treated with either fibrinolysis or primary percutaneous coronary intervention (a Danish Trial in Acute Myocardial Infarction-2 Substudy).
    Idorn L, Høfsten DE, Wachtell K, Mølgaard H, Egstrup K, DANAMI-2 Investigators.
    Am J Cardiol; 2007 Sep 15; 100(6):937-43. PubMed ID: 17826373
    [Abstract] [Full Text] [Related]

  • 3. Comparison of myocardial reperfusion in patients undergoing percutaneous coronary intervention in ST-segment elevation acute myocardial infarction with versus without diabetes mellitus (from the EMERALD Trial).
    Marso SP, Miller T, Rutherford BD, Gibbons RJ, Qureshi M, Kalynych A, Turco M, Schultheiss HP, Mehran R, Krucoff MW, Lansky AJ, Stone GW.
    Am J Cardiol; 2007 Jul 15; 100(2):206-10. PubMed ID: 17631071
    [Abstract] [Full Text] [Related]

  • 4. Percutaneous coronary intervention-related time delay, patient's risk profile, and survival benefits of primary angioplasty vs lytic therapy in ST-segment elevation myocardial infarction.
    De Luca G, Cassetti E, Marino P.
    Am J Emerg Med; 2009 Jul 15; 27(6):712-9. PubMed ID: 19751630
    [Abstract] [Full Text] [Related]

  • 5. Impact of time to treatment on mortality after prehospital fibrinolysis or primary angioplasty: data from the CAPTIM randomized clinical trial.
    Steg PG, Bonnefoy E, Chabaud S, Lapostolle F, Dubien PY, Cristofini P, Leizorovicz A, Touboul P, Comparison of Angioplasty and Prehospital Thrombolysis In acute Myocardial infarction (CAPTIM) Investigators.
    Circulation; 2003 Dec 09; 108(23):2851-6. PubMed ID: 14623806
    [Abstract] [Full Text] [Related]

  • 6. Does diabetes mellitus abolish the beneficial effect of primary coronary angioplasty on long-term risk of reinfarction after acute ST-segment elevation myocardial infarction compared with fibrinolysis? (A DANAMI-2 substudy).
    Madsen MM, Busk M, Søndergaard HM, Bøttcher M, Mortensen LS, Andersen HR, Nielsen TT, DANAMI-2 Investigators.
    Am J Cardiol; 2005 Dec 01; 96(11):1469-75. PubMed ID: 16310424
    [Abstract] [Full Text] [Related]

  • 7. Effectiveness and cost-effectiveness of facilitated percutaneous coronary intervention compared with primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction transferred from community hospitals.
    Coleman CI, McKay RG, Boden WE, Mather JF, White CM.
    Clin Ther; 2006 Jul 01; 28(7):1054-62. PubMed ID: 16990084
    [Abstract] [Full Text] [Related]

  • 8. Percutaneous coronary intervention in patients receiving enoxaparin or unfractionated heparin after fibrinolytic therapy for ST-segment elevation myocardial infarction in the ExTRACT-TIMI 25 trial.
    Gibson CM, Murphy SA, Montalescot G, Morrow DA, Ardissino D, Cohen M, Gulba DC, Kracoff OH, Lewis BS, Roguin N, Antman EM, Braunwald E, ExTRACT-TIMI 25 Investigators.
    J Am Coll Cardiol; 2007 Jun 12; 49(23):2238-46. PubMed ID: 17560287
    [Abstract] [Full Text] [Related]

  • 9. Effects of pretreatment with clopidogrel on nonemergent percutaneous coronary intervention after fibrinolytic administration for ST-segment elevation myocardial infarction: a Clopidogrel as Adjunctive Reperfusion Therapy-Thrombolysis in Myocardial Infarction (CLARITY-TIMI) 28 study.
    Gibson CM, Murphy SA, Pride YB, Kirtane AJ, Aroesty JM, Stein EB, Ciaglo LN, Southard MC, Sabatine MS, Cannon CP, Braunwald E, TIMI Study Group.
    Am Heart J; 2008 Jan 12; 155(1):133-9. PubMed ID: 18082504
    [Abstract] [Full Text] [Related]

  • 10. Relation between electrocardiographic ST-segment resolution and early and late outcomes after primary percutaneous coronary intervention for acute myocardial infarction.
    Brodie BR, Stuckey TD, Hansen C, VerSteeg DS, Muncy DB, Moore S, Gupta N, Downey WE.
    Am J Cardiol; 2005 Feb 01; 95(3):343-8. PubMed ID: 15670542
    [Abstract] [Full Text] [Related]

  • 11. Long-term prognostic value of ST-segment resolution in patients treated with fibrinolysis or primary percutaneous coronary intervention results from the DANAMI-2 (DANish trial in acute myocardial infarction-2).
    Sejersten M, Valeur N, Grande P, Nielsen TT, Clemmensen P, DANAMI-2 Investigators.
    J Am Coll Cardiol; 2009 Nov 03; 54(19):1763-9. PubMed ID: 19874989
    [Abstract] [Full Text] [Related]

  • 12. Treatment of acute ST-segment elevation myocardial infarction in West Pomerania province of Poland. Comparison between primary coronary intervention and thrombolytic therapy.
    Dryja T, Kornacewicz-Jach Z, Goracy J, Przybycień K, Jodko L, Skowronek A, Kurowski M, Zinka E.
    Kardiol Pol; 2006 Jun 03; 64(6):591-9; discussion 600-1. PubMed ID: 16810577
    [Abstract] [Full Text] [Related]

  • 13. Is primary angioplasty more effective than prehospital fibrinolysis in diabetics with acute myocardial infarction? Data from the CAPTIM randomized clinical trial.
    Bonnefoy E, Steg PG, Chabaud S, Dubien PY, Lapostolle F, Boudet F, Lacroute JM, Dissait F, Vanzetto G, Leizorowicz A, Touboul P.
    Eur Heart J; 2005 Sep 03; 26(17):1712-8. PubMed ID: 15840623
    [Abstract] [Full Text] [Related]

  • 14. Percutaneous coronary intervention after fibrinolysis: a multiple meta-analyses approach according to the type of strategy.
    Collet JP, Montalescot G, Le May M, Borentain M, Gershlick A.
    J Am Coll Cardiol; 2006 Oct 03; 48(7):1326-35. PubMed ID: 17010790
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Primary coronary intervention in diabetic octogenarians with acute ST elevation myocardial infarction.
    Sosnowski C, Janeczko-Sosnowska E, Woźniak J, Jasiński B, Dabrowski R, Sumiński A, Wiernikowski A, Ostrzycki A, Szwed H, Ruzyłło W.
    Kardiol Pol; 2007 Oct 03; 65(10):1181-6; discussion 1187-9. PubMed ID: 17979046
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of immediate angioplasty versus ischemia-guided management after thrombolysis in acute myocardial infarction in areas with very long transfer distances results of the NORDISTEMI (NORwegian study on DIstrict treatment of ST-elevation myocardial infarction).
    Bøhmer E, Hoffmann P, Abdelnoor M, Arnesen H, Halvorsen S.
    J Am Coll Cardiol; 2010 Jan 12; 55(2):102-10. PubMed ID: 19747792
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.